Deerfield Management Partners with AWS to Drive AI Innovations in Healthcare

Deerfield Management Partners with AWS for AI Innovations in Healthcare



On November 9, 2026, Deerfield Management, an investment firm dedicated to the advancement of healthcare, announced a groundbreaking collaboration with Amazon Web Services (AWS). This partnership aims to expedite the development and scalability of companies in the healthcare and life sciences sectors that leverage artificial intelligence (AI).

The collaboration will merge AWS’s generative AI and cloud services with Deerfield Intelligence's skilled team of AI engineers. This joint effort is designed to empower a selection of Deerfield’s portfolio companies to implement advanced AI systems across critical areas including drug discovery, operational automation, and care delivery. Moreover, the partnership will enhance Deerfield’s internal capabilities by integrating AWS's AI resources into their research, evaluation, and operational workflows.

As a significant development in this expanded relationship, AWS will serve as the preferred AI provider for Deerfield and its chosen portfolio companies. The Deerfield Intelligence and Deerfield Discovery and Development (3DC) teams will gain access to AWS’s premier AI and cloud technology, enhancing their proprietary healthcare AI products and disseminating AI capabilities among interested portfolio companies. Furthermore, selected companies within Deerfield's portfolio will receive not only access to AWS’s AI and cloud infrastructure but also the necessary technical training on large-scale model training, inference optimization, and healthcare-centric managed services.

Dan Sheeran, Vice President, and General Manager of Healthcare and Life Sciences at AWS, emphasized the partnership’s goal, stating, “This collaboration aims to drive the development of the next generation of AI-powered healthcare organizations.” He noted that with AWS's support, the involved portfolio companies can utilize tailored AI services, such as Amazon Bio Discovery, alongside capabilities offered by Amazon Bedrock AgentCore, thus facilitating the building of AI agents and supporting organizations in ways previously unattainable.

Jim Flynn, Managing Partner at Deerfield, underscored the firm’s vision to establish a robust AI-native platform within healthcare. According to Flynn, “Our Intelligence team is developing models that aim to transform how we source opportunities, evaluate science, and fast-track portfolio companies.” With AWS's advanced healthcare services, Deerfield hopes to significantly shorten development timelines for its companies as they work toward developing innovative clinical solutions.

This collaboration builds on the promising momentum already established within Deerfield’s portfolio. For example, Ascertain—a healthcare technology business supported by Deerfield—effectively utilizes AWS services as part of its AI platform, streamlining complex clinical and administrative workflows such as case management and prior authorization. Mark Michalski, M.D., Chief Information Officer at Deerfield and CEO of Ascertain, stated, “We built Ascertain to give clinicians back their time by alleviating the administrative burdens in care, and we believe AWS’s industry-specific services will help us expand these capabilities.”

The enhanced collaboration between Deerfield and AWS is set against the backdrop of Deerfield's commitment to fostering innovation within healthcare, a commitment that is rooted in its location in New York City—a hub for one of the world’s densest healthcare ecosystems, populated by esteemed academic medical centers, a burgeoning biotech industry, and a vast network of clinicians and investors.

The Deerfield team includes over 190 professionals, featuring more than 60 experts with MD, JD, and PhD credentials. Looking ahead, Deerfield and AWS intend to host joint programs at Cure, Deerfield’s healthcare innovation campus, thereby transforming the facility into a collaborative hub for the healthcare innovation community.

About Deerfield Management



Deerfield Management Company is a dedicated investment management firm focused on advancing healthcare through strategic investments, insightful intelligence, and philanthropic efforts. With its headquarters located at Cure—a medical innovation campus in New York City—Deerfield encompasses Deerfield Discovery and Development (3DC) and Deerfield Intelligence. The firm operates across the healthcare ecosystem to align talent, capital, concepts, and technology in dynamic and collaborative manners. For further information, visit www.deerfield.com.

Topics Health)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.